830 related articles for article (PubMed ID: 15698840)
41. Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors.
Pariente N; Mao SH; Morizono K; Chen IS
J Gene Med; 2008 Mar; 10(3):242-8. PubMed ID: 18074400
[TBL] [Abstract][Full Text] [Related]
42. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
43. High-efficient lentiviral vector-mediated gene transfer into primary human NK cells.
Micucci F; Zingoni A; Piccoli M; Frati L; Santoni A; Galandrini R
Exp Hematol; 2006 Oct; 34(10):1344-52. PubMed ID: 16982327
[TBL] [Abstract][Full Text] [Related]
44. A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes.
Sakoda T; Kasahara N; Hamamori Y; Kedes L
J Mol Cell Cardiol; 1999 Nov; 31(11):2037-47. PubMed ID: 10591030
[TBL] [Abstract][Full Text] [Related]
45. Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
Roche C; Zamora AJ; Taïeb D; Lavaque E; Rasolonjanahary R; Dufour H; Bagnis C; Enjalbert A; Barlier A
J Endocrinol; 2004 Oct; 183(1):217-33. PubMed ID: 15525589
[TBL] [Abstract][Full Text] [Related]
46. Characterization of recombinant adeno-associated virus-2 as a vehicle for gene delivery and expression into vascular cells.
Gnatenko D; Arnold TE; Zolotukhin S; Nuovo GJ; Muzyczka N; Bahou WF
J Investig Med; 1997 Feb; 45(2):87-98. PubMed ID: 9084579
[TBL] [Abstract][Full Text] [Related]
47. Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model.
Kyriakou CA; Yong KL; Benjamin R; Pizzey A; Dogan A; Singh N; Davidoff AM; Nathwani AC
J Gene Med; 2006 Mar; 8(3):253-64. PubMed ID: 16288493
[TBL] [Abstract][Full Text] [Related]
48. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
49. Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging.
Pfeifer A; Kessler T; Yang M; Baranov E; Kootstra N; Cheresh DA; Hoffman RM; Verma IM
Mol Ther; 2001 Mar; 3(3):319-22. PubMed ID: 11273773
[TBL] [Abstract][Full Text] [Related]
50. Self-inactivating lentiviral vectors with U3 and U5 modifications.
Iwakuma T; Cui Y; Chang LJ
Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
[TBL] [Abstract][Full Text] [Related]
51. Adenoviral vector design for high-level transgene expression in primitive human hematopoietic progenitors.
Fan X; Brun A; Karlsson S
Gene Ther; 2000 Dec; 7(24):2132-8. PubMed ID: 11223995
[TBL] [Abstract][Full Text] [Related]
52. Multigene lentiviral vectors based on differential splicing and translational control.
Zhu Y; Feuer G; Day SL; Wrzesinski S; Planelles V
Mol Ther; 2001 Oct; 4(4):375-82. PubMed ID: 11592842
[TBL] [Abstract][Full Text] [Related]
53. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state.
Schalch P; Rahman GF; Patejunas G; Goldschmidt RA; Carbray J; Retuerto MA; Kim D; Esser K; Crystal RG; Rosengart TK
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):535-40. PubMed ID: 14762365
[TBL] [Abstract][Full Text] [Related]
54. Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis.
Serafini M; Bonamino M; Golay J; Introna M
Haematologica; 2004 Jan; 89(1):86-95. PubMed ID: 14754610
[TBL] [Abstract][Full Text] [Related]
55. The application of a lentiviral vector for gene transfer in fetal human hepatocytes.
Zahler MH; Irani A; Malhi H; Reutens AT; Albanese C; Bouzahzah B; Joyce D; Gupta S; Pestell RG
J Gene Med; 2000; 2(3):186-93. PubMed ID: 10894264
[TBL] [Abstract][Full Text] [Related]
56. G2 cell cycle arrest and cyclophilin A in lentiviral gene transfer.
Zhang S; Joseph G; Pollok K; Berthoux L; Sastry L; Luban J; Cornetta K
Mol Ther; 2006 Oct; 14(4):546-54. PubMed ID: 16901758
[TBL] [Abstract][Full Text] [Related]
57. Adeno-associated virus vectors for vascular gene delivery.
Lynch CM; Hara PS; Leonard JC; Williams JK; Dean RH; Geary RL
Circ Res; 1997 Apr; 80(4):497-505. PubMed ID: 9118480
[TBL] [Abstract][Full Text] [Related]
58. In vivo transduction of HIV-1-derived lentiviral particles engineered for macrolide-adjustable transgene expression.
Mitta B; Weber CC; Fussenegger M
J Gene Med; 2005 Nov; 7(11):1400-8. PubMed ID: 15999397
[TBL] [Abstract][Full Text] [Related]
59. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
60. Feline immunodeficiency virus and retrovirus-mediated adventitial ex vivo gene transfer to rabbit carotid artery using autologous vascular smooth muscle cells.
Kankkonen HM; Turunen MP; Hiltunen MO; Lehtolainen P; Koponen J; Leppänen P; Turunen AM; Ylä-Herttuala S
J Mol Cell Cardiol; 2004 Mar; 36(3):333-41. PubMed ID: 15010272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
